These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
156 related articles for article (PubMed ID: 31941074)
41. Enhanced transdermal delivery of lornoxicam by nanostructured lipid carrier gels modified with polyarginine peptide for treatment of carrageenan-induced rat paw edema. Gao S; Tian B; Han J; Zhang J; Shi Y; Lv Q; Li K Int J Nanomedicine; 2019; 14():6135-6150. PubMed ID: 31447556 [No Abstract] [Full Text] [Related]
42. Daidzein-loaded nanostructured lipid carriers-PLGA nanofibers for transdermal delivery. Song J; Fan X; Shen Q Int J Pharm; 2016 Mar; 501(1-2):245-52. PubMed ID: 26851353 [TBL] [Abstract][Full Text] [Related]
43. Effect of Oil Content on Physiochemical Characteristics of γ-Oryzanol-Loaded Nanostructured Lipid Carriers. Pornputtapitak W; Pantakitcharoenkul J; Teeranachaideekul V; Sinthiptharakoon K; Sapcharoenkun C; Meemuk B J Oleo Sci; 2019 Aug; 68(8):699-707. PubMed ID: 31292337 [TBL] [Abstract][Full Text] [Related]
44. Nanostructured lipid carriers versus microemulsions for delivery of the poorly water-soluble drug luteolin. Liu Y; Wang L; Zhao Y; He M; Zhang X; Niu M; Feng N Int J Pharm; 2014 Dec; 476(1-2):169-77. PubMed ID: 25280882 [TBL] [Abstract][Full Text] [Related]
45. Preparation of tilmicosin-resin complex microsphere and its Pharmacokinetics study in rat. Li D; Zou K; Wang X; Huang Q; Li S; Zuo H; Hu C; Li Z Pak J Pharm Sci; 2020 Sep; 33(5):2143-2151. PubMed ID: 33824123 [TBL] [Abstract][Full Text] [Related]
46. Efficacy of Tylosin and Tilmicosin Against Experimental Garmyn A; Vereecken M; De Gussem K; Depondt W; Haesebrouck F; Martel A Avian Dis; 2019 Jun; 63(2):359-365. PubMed ID: 31251538 [TBL] [Abstract][Full Text] [Related]
47. Enhancement of oral bioavailability of cyclosporine A: comparison of various nanoscale drug-delivery systems. Wang K; Qi J; Weng T; Tian Z; Lu Y; Hu K; Yin Z; Wu W Int J Nanomedicine; 2014; 9():4991-9. PubMed ID: 25378925 [TBL] [Abstract][Full Text] [Related]
48. High payload nanostructured lipid carriers fabricated with alendronate/polyethyleneimine ion complexes. Abd El-Hamid BN; Swarnakar NK; Soliman GM; Attia MA; Pauletti GM Int J Pharm; 2018 Jan; 535(1-2):148-156. PubMed ID: 29104057 [TBL] [Abstract][Full Text] [Related]
49. Nanostructured lipid carriers for the topical delivery of tretinoin. Ghate VM; Lewis SA; Prabhu P; Dubey A; Patel N Eur J Pharm Biopharm; 2016 Nov; 108():253-261. PubMed ID: 27519827 [TBL] [Abstract][Full Text] [Related]
50. Mechanism of transport of saquinavir-loaded nanostructured lipid carriers across the intestinal barrier. Beloqui A; Solinís MÁ; Gascón AR; del Pozo-Rodríguez A; des Rieux A; Préat V J Control Release; 2013 Mar; 166(2):115-23. PubMed ID: 23266764 [TBL] [Abstract][Full Text] [Related]
51. Comparison of different aliphatic acid grafted N-trimethyl chitosan surface-modified nanostructured lipid carriers for improved oral kaempferol delivery. Du Q; Chen J; Yan G; Lyu F; Huang J; Ren J; Di L Int J Pharm; 2019 Sep; 568():118506. PubMed ID: 31302169 [TBL] [Abstract][Full Text] [Related]
52. Improvement of oral bioavailability of lovastatin by using nanostructured lipid carriers. Zhou J; Zhou D Drug Des Devel Ther; 2015; 9():5269-75. PubMed ID: 26425076 [TBL] [Abstract][Full Text] [Related]
53. Hyaluronic acid modified nanostructured lipid carriers for transdermal bupivacaine delivery: In vitro and in vivo anesthesia evaluation. Yue Y; Zhao D; Yin Q Biomed Pharmacother; 2018 Feb; 98():813-820. PubMed ID: 29571251 [TBL] [Abstract][Full Text] [Related]
54. Preparation and in vitro-in vivo evaluation of ofloxacin loaded ophthalmic nano structured lipid carriers modified with chitosan oligosaccharide lactate for the treatment of bacterial keratitis. Ustündağ-Okur N; Gökçe EH; Bozbıyık Dİ; Eğrilmez S; Ozer O; Ertan G Eur J Pharm Sci; 2014 Oct; 63():204-15. PubMed ID: 25111119 [TBL] [Abstract][Full Text] [Related]
55. Biocompatible Lipid Nanoparticles as Carriers To Improve Curcumin Efficacy in Ovarian Cancer Treatment. Bondì ML; Emma MR; Botto C; Augello G; Azzolina A; Di Gaudio F; Craparo EF; Cavallaro G; Bachvarov D; Cervello M J Agric Food Chem; 2017 Feb; 65(7):1342-1352. PubMed ID: 28111949 [TBL] [Abstract][Full Text] [Related]
56. Hydrogenated castor oil nanoparticles as carriers for the subcutaneous administration of tilmicosin: in vitro and in vivo studies. Han C; Qi CM; Zhao BK; Cao J; Xie SY; Wang SL; Zhou WZ J Vet Pharmacol Ther; 2009 Apr; 32(2):116-23. PubMed ID: 19290940 [TBL] [Abstract][Full Text] [Related]
57. Development of solid lipid nanoparticles and nanostructured lipid carriers for improving ocular delivery of acyclovir. Seyfoddin A; Al-Kassas R Drug Dev Ind Pharm; 2013 Apr; 39(4):508-19. PubMed ID: 22424312 [TBL] [Abstract][Full Text] [Related]
58. Nanostructured lipid carriers and their current application in targeted drug delivery. Jaiswal P; Gidwani B; Vyas A Artif Cells Nanomed Biotechnol; 2016; 44(1):27-40. PubMed ID: 24813223 [TBL] [Abstract][Full Text] [Related]
59. A new topical formulation for psoriasis: development of methotrexate-loaded nanostructured lipid carriers. Pinto MF; Moura CC; Nunes C; Segundo MA; Costa Lima SA; Reis S Int J Pharm; 2014 Dec; 477(1-2):519-26. PubMed ID: 25445970 [TBL] [Abstract][Full Text] [Related]
60. Brain Delivery of Curcumin Using Solid Lipid Nanoparticles and Nanostructured Lipid Carriers: Preparation, Optimization, and Pharmacokinetic Evaluation. Sadegh Malvajerd S; Azadi A; Izadi Z; Kurd M; Dara T; Dibaei M; Sharif Zadeh M; Akbari Javar H; Hamidi M ACS Chem Neurosci; 2019 Jan; 10(1):728-739. PubMed ID: 30335941 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]